MultiCell Technologies entered into a worldwide, exclusive license and technology purchase agreement with Corning related to its Fa2N-4 immortalized adult human liver cell lines.

This marks the second supply collaboration related to its treatment of chronic fatigue in MS patients. MultiCell Technologies entered into an agreement with Merck KGaA & Co. for the formulation ...

MultiCell Technologies, Inc. and Living Cell Technologies Limited have announced that the parties have entered into a joint venture to develop therapeutic liver cell applications.The collaboration ...

MultiCell Technologies, Inc. and Living Cell Technologies Limited (LCT) have announced that the parties have entered into a joint venture to develop therapeutic liver cell applications. The ...

WOONSOCKET, R.I., July 11, 2011 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) ("MultiCell") today announced that it entered into a sponsored research agreement with ...